Amy L. Lark

Overexpression of focal adhesion kinase in primary colorectal carcinomas and colorectal liver metastases: immunohistochemistry and real-time PCR analyses.

C. Livasy, L. Caskey, B. Calvo, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Multicenter clinical validation of PITX2 methylation as a prostate specific antigen recurrence predictor in patients with post-radical prostatectomy prostate cancer.

S. Freedland, T. Wheeler, M. Ittmann, 2010, The Journal of urology.

Is Ki67 prognostic for aggressive prostate cancer? A multicenter real-world study.

C. Galet, I. Csizmadi, S. Freedland, 2018, Biomarkers in medicine.

Upregulation of focal adhesion kinase (FAK) expression in ductal carcinoma in situ (DCIS) is an early event in breast tumorigenesis

C. Livasy, D. Cowan, L. Dressler, 2004, Breast Cancer Research and Treatment.

Intratumoral inflammation is associated with more aggressive prostate cancer

S. Freedland, R. Vollmer, L. Gerber, 2013, World Journal of Urology.

Development and clinical validation of a real-time PCR assay for PITX2 DNA methylation to predict prostate-specific antigen recurrence in prostate cancer patients following radical prostatectomy.

G. Kristiansen, D. Dietrich, S. Freedland, 2013, The Journal of molecular diagnostics : JMD.

Prostate biopsies from black men express higher levels of aggressive disease biomarkers than prostate biopsies from white men

S. Freedland, D. Moreira, R. Vollmer, 2011, Prostate Cancer and Prostatic Diseases.

Association between Statins and Prostate Tumor Inflammatory Infiltrate in Men Undergoing Radical Prostatectomy

S. Freedland, R. Vollmer, R. Hamilton, 2010, Cancer Epidemiology, Biomarkers & Prevention.

High focal adhesion kinase expression in invasive breast carcinomas is associated with an aggressive phenotype

Joseph Geradts, William Cance, Lynn Dressler, 2005, Modern Pathology.

Endobronchial metastasis from primary anorectal melanoma

B. Heyman, A. Lark, S. Shofer, 2013, The American journal of case reports.

Is Ki67 prognostic for aggressive prostate cancer? A multicenter real-world study.

C. Galet, I. Csizmadi, S. Freedland, 2018, Biomarkers in medicine.